A Robust Metatranscriptomic Technology for Population-Scale Studies of Diet, Gut Microbiome, and Human Health.

A clinically validated human capillary blood transcriptome test for global systems biology studies.

The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer.

Gut microbiome activity contributes to individual variation in glycemic response in adults.

Pathogen detection and characterization from throat swabs using unbiased metatranscriptomic analyses.

A clinically validated human saliva metatranscriptomic test for global systems biology studies.

Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.

Investigating the association between the symptoms of women with Fibromyalgia, Digestive function, and markers of the microbiota of the Gastrointestinal Tract (The FIDGIT Study): study protocol

Comparison of the gut microbiome composition between men with erectile dysfunction and a matched cohort: a pilot study

Detecting salivary host and microbiome RNA signature for aiding diagnosis of oral and throat cancer.

Comparison of the gut microbiome composition between men with Peyronie's disease and a matched cohort: a pilot study.

Data-Driven Precision Nutrition Improves Clinical Outcomes and Risk Scores for IBS, Depression, Anxiety, and T2D.

An accurate aging clock developed from large-scale gut microbiome and human gene expression data

A novel method for sampling subgingival microbiome - a comparative metatranscriptomic study.

Microbial functional pathways based on metatranscriptomic profiling enable effective saliva-based health assessments for precision wellness.

Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort

The effectiveness of precision supplements on depression symptoms in a US population.

Preparation of robust Synthetic Control samples and their use in a metatranscriptomic clinical test.

Sub-optimal activity of gut microbiome functional pathways increases the odds of Irritable Bowel Syndrome in a large adult human population.